Literature DB >> 35673429

Family history of menstrual irregularity or diabetes mellitus enhances the susceptibility to polycystic ovary syndrome among subjects harboring rs7903146 genetic variant of TCF7L2.

Rabiya Rashid1,2,3, Idrees A Shah2, Mir M Asrar2, Meena Godha1, Bashir A Ganai4, Mohd Ashraf Ganie2,3.   

Abstract

Purpose: TCF7L2 mediated Wnt signaling cascade regulates glucose homeostasis by orchestrating expression, processing, and hepatic clearance of insulin. Type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS) significantly overlap in pathophysiological features with insulin resistance as a central driver. While TCF7L2 is the most potent T2DM locus, studies on the association of TCF7L2 with PCOS are limited and inconclusive. Therefore, in addition to expression profiling, the association of TCF7L2 polymorphic variant rs7903146 with PCOS was evaluated.
Methods: Using Rotterdam-2003 criteria for the diagnosis, 120 PCOS cases, and 120 age-matched controls were recruited. Subjects underwent clinical, biochemical, and hormonal assessment, followed by genotyping for rs7903146, carried out by PCR-RFLP and TCFL2 expression profiling by qRT-PCR. Genotype-phenotype correlation analysis was performed to evaluate any such associations. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were computed by conditional logistic regression.
Results: Higher odds of developing PCOS were observed in the women having a family history (FH) of either T2DM (OR = 3.86, 95% CI:1.90 - 7.83), hirsutism (OR = 4.74. 95%CI: 1.91 - 17.21) or menstrual irregularities (MI) (OR = 3.07, 95%CI: 1.61 - 8.54). The genotypes of rs7903146 did not confer any risk for developing PCOS (OR = 0.46;95%CI: 0.15 - 2.03). However, the elevated risk was seen in the subjects who harbored the variant allele and had FH of either T2DM (OR = 6.71; 95%CI: 1.89 - 23.78) or MI (OR = 9.71; 95% CI:1.89 - 23.78).
Conclusion: TCF7L2 polymorphic variant rs7903146 is not independently linked to PCOS risk, but modulates the risk in the subjects having a family history of either T2DM or MI. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-022-01050-y. © Springer Nature Switzerland AG 2022.

Entities:  

Keywords:  Diabetes mellitus; Gene polymorphism; Insulin resistance; Kashmir; Menstrual irregularity, Polycystic ovary syndrome; TCF7L2

Year:  2022        PMID: 35673429      PMCID: PMC9167401          DOI: 10.1007/s40200-022-01050-y

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  42 in total

1.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

Review 2.  Familial polycystic ovarian disease.

Authors:  J R Givens
Journal:  Endocrinol Metab Clin North Am       Date:  1988-12       Impact factor: 4.741

3.  [Study on parents phenotypes in women with polycystic ovary syndrome].

Authors:  W Mao; M Li; Y Zhao
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2000-10

Review 4.  Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Ramon Bossardi Ramos; Vitor Costa Fabris; Letícia de Almeida Brondani; Poli Mara Spritzer
Journal:  Endocrine       Date:  2015-02-13       Impact factor: 3.633

Review 5.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

6.  Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients.

Authors:  Shlomit Kenigsberg; Yaakov Bentov; Vered Chalifa-Caspi; Gad Potashnik; Rivka Ofir; Ohad S Birk
Journal:  Mol Hum Reprod       Date:  2009-01-13       Impact factor: 4.025

7.  Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.

Authors:  Surleen Kaur; Kellie J Archer; M Gouri Devi; Alka Kriplani; Jerome F Strauss; Rita Singh
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

8.  Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.

Authors:  Luan Shu; Nadine S Sauter; Fabienne T Schulthess; Aleksey V Matveyenko; José Oberholzer; Kathrin Maedler
Journal:  Diabetes       Date:  2007-12-10       Impact factor: 9.461

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.

Authors:  Elisabeth Lerchbaum; Verena Schwetz; Albrecht Giuliani; Barbara Obermayer-Pietsch
Journal:  Eur J Endocrinol       Date:  2014-04-10       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.